Annalisa Chiappella

20PUBLICATIONS
91CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursChemotherapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 05, 2026
Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE study.

|Aug 05, 2025
Outcomes of CAR T-cell therapy in high-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis.

Anna Dodero, Giusy Ceparano, Beatrice Casadei

|Dec 23, 2024
Brexucabtagene autoleucel in-vivo expansion and BTKi refractoriness have a negative influence on progression-free survival in mantle cell lymphoma: Results from CART-SIE study.

Federico Stella, Annalisa Chiappella, Martina Magni

|Oct 09, 2024
Role of bridging RT in relapsed/refractory diffuse large B-cell lymphoma undergoing CAR-T therapy: a multicenter study.

Stefania Bramanti, Daniele Mannina, Annalisa Chiappella

|Jul 02, 2024
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas.

Federico Stella, Annalisa Chiappella, Beatrice Casadei

|Jun 15, 2024
Secondary primary malignancies after CD-19 directed CAR-T-cell therapy in lymphomas: A report from the Italian CART-SIE study.

Angelica Barone, Annalisa Chiappella, Beatrice Casadei

Pageof 4

Frequent Collaborators

10 joint publications

Paolo Corradini

8 joint publications

Pierluigi Zinzani

4 joint publications

Francesca Bonifazi

4 joint publications

Patrizia Chiusolo